Reliance Global Group Inc. (EZRA) Earnings
Reliance Global Group Inc. is expected to report next earnings on August 18, 2026 (in NaN days).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Mar 10, 2026 | — | $-0.25 | — | $3M | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 7, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
- The company focused on simplifying the business, strengthening the balance sheet, and creating a framework for long-term growth. - Insurance segment: Continued to operate a streamlined and efficient business post-portfolio realignment in 2025. ReliExchange remains central, with the rollout of ReliExchange 2.0 to enhance scalability, agent onboarding, and operating efficiency. 5minuteinsured.com supports direct-to-consumer acquisition. - Strategic ventures segment: Ezra International Group and Scale 51 model are driving execution. Ezra International identifies and evaluates opportunities in technology and life sciences, while Scale 51 structures investments, deploys capital progressively, and expands ownership. Examples include investment in Quantum with milestone-based ownership increase and launch of LifeSci Global Group with investment in Invernate, a developer of positron emission tomography imaging and therapeutic radiopharmaceuticals.
Segment performance
The company has two segments. The insurance segment had net income of $0.7 million for Q1 2026, up from $0.5 million in the prior year period, driven by lower operating expenses, efficiencies from the one-firm initiative, and 11% organic revenue growth from retained businesses. The strategic ventures segment had a net loss of $0.4 million, primarily reflecting costs associated with the launch and ongoing development of Ezra International Group and Scale 51 operating models, as well as equity investment loss related to the investment in quantum.
Analyst Q&A
Q: Chaim Englender asked about Zcash and if more will be done, and if Zcash is listed as an asset.
A: Ezra said they did Zcash smartly, it's on the balance sheet under digital assets.
Q: Nicole Kaufman asked about the quantum model milestones and pace of deployment.
A: Moshe Fishman said milestones are based on risk reduction for increasing ownership, and they are selective in reviewing and partnering with companies for investments.
Q: Nicole Kaufman asked about organic revenue growth in insurance and how the insurance platform contributes to strategy.
A: Ezra said the insurance platform grew 11% due to growth in agents (from 60-something to over 300) and use of AI to supercharge the business.
Q: Nicole Kaufman asked about strategic rationale behind LifeSci Global Group and evaluation of opportunities like Invernate.
A: Ezra said LifeSci Global Group focuses on companies with proven performance, good teams (like Scott Corman and David Turner with successful exits), and it helps the world, such as curing rare child diseases.